Keyword: Teva Copaxone


Teva Pharmaceutical Banks on Thrice-weekly Copaxone

02.05.2013 - Teva Pharmaceutical Industries is banking on approval in early 2014 for a new thrice-weekly version of its multiple sclerosis treatment Copaxone to bolster sales ahead of a likely...


Teva Pharmaceutical Adjusted Profit Tops Estimates

01.11.2012 - Teva Pharmaceutical Industries, the world's biggest generic drugmaker, posted adjusted quarterly profit that beat expectations as strong U.S. revenue offset lower European generic...


Sanofi Draws Fire Over Cost of MS Drug Lemtrada

01.11.2012 - Medical journal The Lancet warned that Sanofi's experimental multiple sclerosis drug Lemtrada may be too costly for patients and health insurers once it gets approved by regulators...